For citations:
Dyakov I.N., Kasyan G.R. Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2021;(1):35-45. (In Russ.) https://doi.org/10.37489/2588-0519-2021-1-35-45
Views PDF (Rus): 417
Email this article 